Celltrion developed and manufactured the world’s first monoclonal antibody biosimilar, followed by the first and only subcutaneous (SC) formulation infliximab, ‘Remsima ® SC’, which was ...

and infliximab, for diseases such as inflammatory bowel disease and rheumatoid arthritis. The latest version of AlphaFold can predict the structure of proteins bound to drug-like small molecules.